Literature DB >> 30366033

Chemogenetic activation of glutamatergic neurons in the motor cortex promotes functional recovery after ischemic stroke in rats.

Ke-Hui Hu1, Yang-An Li2, Wei Jia3, Guang-Yan Wu4, Lin Sun4, San-Rong Wang5, Le-Hua Yu6.   

Abstract

Ischemic stroke is a major cause of disability and mortality worldwide, while no unequivocally efficacious drug is currently available to treat post-stroke functional impairments. Animal and clinical investigations suggest that the motor cortex stimulation constitutes a particularly promising approach for promoting function recovery after stroke. However, the cell types and mechanisms involved in stimulation-induced recovery are not well understood. Here, we used chemogenetic technique to selectively activate glutamatergic neurons in the primary motor cortex and investigated whether activation of glutamatergic neurons in the primary motor cortex can promote functional recovery after ischemic stroke in rats. The results showed that chemogenetic activation of the motor cortex glutamatergic neurons significantly decreased the neurological deficit scores, as well as significantly increased the grip test scores and the hanging time. Moreover, the glutamatergic neuronal activation also significantly decreased the escape latencies, increased the swimming speed, target quadrant time, and numbers of crossing platform position in the Morris water maze test. These results demonstrate that selective activation of the glutamatergic neurons in primary motor cortex is sufficient to promote functional recovery after ischemic stroke, and may be of importance in understanding the neural cellular mechanisms underlying the motor cortex stimulation-induced functional recovery.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemogenetics; Functional recovery; Glutamatergic neurons; Ischemic stroke; Motor cortex

Mesh:

Substances:

Year:  2018        PMID: 30366033     DOI: 10.1016/j.bbr.2018.10.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

1.  Clozapine-Induced Chemogenetic Neuromodulation Rescues Post-Stroke Deficits After Chronic Capsular Infarct.

Authors:  Jongwook Cho; Seungjun Ryu; Sunwoo Lee; Junsoo Kim; Ji-Young Park; Hyuk-Sang Kwon; Hyoung-Ihl Kim
Journal:  Transl Stroke Res       Date:  2022-07-09       Impact factor: 6.829

Review 2.  Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.

Authors:  Jingwei Song; Ruchit V Patel; Massoud Sharif; Anagha Ashokan; Michael Michaelides
Journal:  Mol Ther       Date:  2021-12-01       Impact factor: 11.454

3.  Phase-specific manipulation of neuronal activity: a promising stroke therapy approach.

Authors:  Dennis A Turner; Wei Yang
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

4.  Level of hM4D(Gi) DREADD Expression Determines Inhibitory and Neurotoxic Effects in the Hippocampus.

Authors:  Marie-Gabrielle Goossens; Lars Emil Larsen; Marijke Vergaelen; Wytse Wadman; Chris Van den Haute; Wayra Brackx; Silke Proesmans; Jana Desloovere; Emma Christiaen; Erine Craey; Christian Vanhove; Kristl Vonck; Paul Boon; Robrecht Raedt
Journal:  eNeuro       Date:  2021-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.